Genomatica completes 90 M$ financing and strengthens partnership with Ginkgo Bioworks
Type of post: FLASH NEWS.
- Genomatica
has just announced that it has issued 90 M$ in its latest equity offering,
strengthening its balance sheet to fully execute on its business plan and fuel
new growth opportunities.
- Main participants: Casdin Capital (new lead investor), Viking Global (returning investor and largest
shareholder) and Ginkgo Bioworks
(organism engineering partner).
- Genomatica have also announced that it is
extending its relationship with Ginkgo to accelerate biotechnology innovations
for widely-used chemicals. Ginkgo will now provide expanded access to their
foundry capabilities and services, while increasing its equity stake in
Genomatica.
Press release: Genomatica
Completes $90 Million Financing to Drive Technologies for More Sustainable
Everyday Products, 3/10/2018.
Related posts:
- Novamont
opens a commercial-scale BDO biorefinery in Italy with technology of Genomatica,
30/9/2016.
- Aquafil
and Genomatica come together to develop sustainable caprolactam for bio-nylon
products, 26/1/2018.
Figure 1. Genomatica strengthens partnership with
Ginkgo Bioworks